Literature DB >> 10828874

Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.

R Cabrera1, F Díaz-Espada, Y Barrios, M Briz, R Forés, L Barbolla, I Sanjuán, C Regidor, F J Peñalver, M N Fernández.   

Abstract

A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling. After transplantation, the disease relapsed. Melphalan therapy followed by reinfusion of haemopoietic blood stem cells collected from the patient led to the improvement of the clinical status, although mixed chimerism and an elevated serum IgA persisted. Successful donor immunisation against an immunogenic preparation of the recipient monoclonal protein was performed before the infusion of donor T lymphocytes (DLI) into the patient. Ten weeks after the lymphocyte infusions, no monoclonal band was evidenced and donor complete chimerism was detected. The patient did not develop GVHD. Once complete remission was achieved, the idiotype vaccine was administered to the patient. Nineteen months after DLI, the patient remains in remission. Bone Marrow Transplantation (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828874     DOI: 10.1038/sj.bmt.1702399

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  GM-CSF and IL-12 production by malignant plasma cells promotes cell-mediated immune responses against monoclonal Ig determinants in a light chain myeloma model.

Authors:  H R Galea; M Cogné
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 2.  Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies.

Authors:  E H Warren; H J Deeg
Journal:  Tissue Antigens       Date:  2013-04

3.  Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

Authors:  M Foglietta; S S Neelapu; L W Kwak; Y Jiang; D Nattamai; S-T Lee; D H Fowler; C Sportes; R E Gress; S M Steinberg; L M Vence; L Radvanyi; K C Dwyer; M H Qazilbash; R N K Bryant; M R Bishop
Journal:  Bone Marrow Transplant       Date:  2012-07-09       Impact factor: 5.483

4.  Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.

Authors:  Israel Henig; Tsila Zuckerman
Journal:  Rambam Maimonides Med J       Date:  2014-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.